124605-42-1Relevant articles and documents
Asymmetric synthesis of taxol and taxotere side chains by enolate hydroxylation
Hanessian,Sanceau
, p. 621 - 624 (1996)
We report an asymmetric synthesis of the taxol and taxotere side chains by hydroxylation of enolates derived from N-substituted methyl 3-amino-3-phenyl propionate with the oxodiperoxymolybdenum (pyridine) (hexamethyl phosphoric triamide) complex (MoOPH). We report an asymmetric synthesis of the taxol and taxotere side chains by hydroxylation of enolates derived from N-substituted methyl 3-amino-3-phenyl propionate with the oxodiperoxymolybdenum (pyridine) (hexamethyl phosphoric triamide) complex (MoOPH).
Chiral calcium iodide for asymmetric mannich-type reactions of malonates with imines providing β-aminocarbonyl compounds
Tsubogo, Tetsu,Shimizu, Shota,Kobayashi, Shu
, p. 872 - 876 (2013)
-
Synthetic method of docetaxel side chain
-
Paragraph 0037; 0039; 0042; 0044; 0047; 0049, (2021/03/31)
The invention relates to a synthetic method of a docetaxel side chain, which comprises the following steps: by using (2R, 3S)-2-hydroxy-3-phenyl-3-(((S)-1-phenethyl)-amino)methyl propionate as a raw material, carrying out reduction reaction in the presence of palladium on carbon and hydrogen to obtain (2R, 3S)-3-phenyl isoserine methyl ester salt, and carrying out di-tert-butyl dicarbonate substitution reaction to obtain (2R, 3S)-3-t-butyloxycarboryl-2-hydroxy-3-Methyl 3-phenylpropionate; preparing (4S, 5R)-3-tert-butoxycarbonyl-2-(4-methoxy phenyl)-4-phenyl-5-oxazoline carboxylic acid methylester from through cyclization protection reaction, and finally hydrolyzing to obtain a docetaxel side chain crude product; and recrystallizing the crude product of the docetaxel side chain, and further purifying to obtain a finished product of the docetaxel side chain. The synthetic method disclosed by the invention is safe, environment-friendly, economical, efficient and suitable for large-scaleindustrial production.
Novel taxane anti-tumor compound as well as synthesis method and application thereof
-
Paragraph 0020, (2017/08/29)
The invention discloses a novel taxane anti-tumor compound shown in a structural formula (I). 10-DAB (10-deacetylbaccatin) is adopted as a raw material, and is condensed with phenylisoserine (side chain) with protected 3'-NH2 and 2'-OH in the presence of condensing agents DCC and DMAP after 7-OH and 10-OH are protected, the side chain and a protecting group on a baccatin ring are simultaneously removed in the presence of zinc powder, and coupling is performed with substituted phenylisoxazole in an alkaline medium to obtain a target product. The compound has relatively high anti-tumor activity. (The structural formula (I) is shown in the description.).